United Therapeutics Corporation (UTHR)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,195,100 1,110,900 1,069,400 1,050,500 984,800 899,800 871,500 728,300 727,300 707,400 630,800 687,400 475,800 462,400 470,900 405,400 514,800 468,600 429,800 527,800
Total assets US$ in thousands 7,364,000 7,123,100 6,723,200 6,495,200 7,167,000 7,023,600 6,681,300 6,346,000 6,044,500 5,781,600 5,543,300 5,359,800 5,169,100 5,048,900 4,844,900 4,641,000 4,615,000 4,411,200 4,219,400 4,025,900
ROA 16.23% 15.60% 15.91% 16.17% 13.74% 12.81% 13.04% 11.48% 12.03% 12.24% 11.38% 12.83% 9.20% 9.16% 9.72% 8.74% 11.15% 10.62% 10.19% 13.11%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,195,100K ÷ $7,364,000K
= 16.23%

United Therapeutics Corporation's return on assets (ROA) has been fluctuating over the past few years. The ROA ranged from a low of 8.74% in March 2021 to a high of 16.23% in December 2024.

Overall, the ROA trend shows some volatility but generally demonstrates improvement towards the end of the period. This indicates that the company has been more effective in generating profits relative to its assets. It is important to continue monitoring the ROA to assess the company's efficiency in utilizing its assets to generate earnings for its shareholders.